ABSTRACT
AIM: To evaluate sleep architecture of patients with Cushing's disease (CD) and to explore whether agouti-related peptide (AgRP) and/or leptin play a permissive role in sleep alterations in patients with active CD. METHODS: We performed polysomnography on 26 patients with active CD and age 26 age- and sex-matched control subjects. Blood samples were obtained from all participants for the analyzes of AgRP and leptin. The laboratory and sleep-related parameters were compared. RESULTS: The groups were similar in age, gender, and body mass index. The CD group had reduced sleep efficiency (71.6 ± 12.1% vs. 78.8 ± 12.6%, p = 0.042) and increased wake after sleep onset (WASO%) (24.7 ± 13.1% vs. 17.4 ± 11.6%, p = 0.040) as compared to control group. Seventeen patients with CD (65.4%) and 18 control subjects (69.2%) had obstructive sleep apnea. Serum AgRP (13.2 ± 7.4 pg/ml vs. 9 ± 3.1, p = 0.029), leptin (59.5 mcg/l, [IQR] 32.6-94.6 vs. 25.3 mcg/l, [IQR] 12.9-57.5, p = 0.007) were higher in CD group. AgRP and leptin correlated negatively with total sleep time, sleep efficiency, stage N2 sleep (%), and positively with WASO%. In multiple regression analyses, serum cortisol (ß = - 0.359, p = 0.042) and AgRP (ß = - 0.481, p = 0.01) were significant predictor of sleep efficiency. AgRP was also significant predictor of WASO% (ß = 0.452 and p < 0.05). CONCLUSIONS: Active CD carries an increased risk of impaired sleep efficiency and continuity which may worsen health-related quality of life. Elevated circulating AgRP and, to a lesser extent, leptin may be associated with decreased sleep efficiency and continuity in patients with CD. Patients with CD who have subjective sleep symptoms should be screened with polysomnography.
Subject(s)
Leptin , Pituitary ACTH Hypersecretion , Humans , Agouti-Related Protein , Pilot Projects , Quality of Life , SleepABSTRACT
OBJECTIVE: Our goal was to evaluate the effect of previous history of direct vision internal urethrotomy (DVIU) on success rate of open urethroplasty in patients with bulbar urethral stricture. PATIENTS AND METHODS: We analyzed 133 patients who underwent open urethroplasty for bulbar urethral stricture between January 2008 and May 2017. Patients with penile and fossa navicularis stricture were excluded. We evaluated the effect of previous history of DVIU on success rate of open urethroplasty in patients with urethral stricture. Success of open urethroplasty was defined as disappear of voiding symptoms with maximum flow rate above 15 ml/s. The patients were followed for complications and outcome. RESULTS: Mean age was 54.05 ± 16.5 years. Mean length of stricture was 23.74 ± 10.23 mm. Mean follow-up was 39.77 ± 28.0 months. A total of 76 patients (57.1%) had no history of DVIU. On the contrary, 15.8% had history of DVIU once, 12% had twice, and 15.2% had more than twice. Success rate of open urethroplasty in patients who had no history of DVIU was 84%. However, this success rate was 71.4% in patients who had history of DVIU (P = 0.001). CONCLUSION: DVIU is easy, simple, and noninvasive technique in treatment of urethral stricture, so it is frequently used among urologists. However, it could not be an alternative technique to open urethroplasty. Internal urethrotomy can be used in some certain indications. Success rate of open urethroplasty can be affected by previous history of any endoscopic procedures.
Subject(s)
Minimally Invasive Surgical Procedures , Urethra/surgery , Urethral Stricture/surgery , Adult , Aged , Endoscopy , Female , Humans , Male , Middle Aged , Minimally Invasive Surgical Procedures/adverse effects , Postoperative Complications , Reoperation , Treatment Outcome , UrinationABSTRACT
OBJECTIVE: We evaluated the patients who are candidates for active surveillance and treated with radical prostatectomy. These patients were compared with other patients who had not met the criteria of active surveillance. METHODS: In total, 135 patients were included in the study. The patients were divided into two groups. The patients in Group 1 had less than three positive cores, Gleason 6 (3 + 3) and PSA level equal to or less than 10 ng/ml. Patients in Group 2 had three or more positive cores, Gleason 6 (3 + 3) and PSA level equal to or higher than 10 ng/ml. Pathological results of each groups were compared. RESULTS: The patients' ages were between 52 and 76, and 50 and 77 in groups 1 and 2, retrospectively. There were 69 and 66 patients in groups 1 and 2, retrospectively. The mean age of patients, PSA levels, PSA density, and prostate volumes were 63.89 ± 5.89 years, 5.82 ± 1.84 ng/ml, 0.14 ± 0.07 and 51.21 ± 31.75 cc (Group 1) and 65.77 ± 6.36 years, 13.65 ± 17.11 ng/ml, 0.63 ± 1.03 and 45.44 ± 26.77 cc (Group 2). T2a, T2c, T3a and T3b were reported in 28 patients, 36 patients, 3 patients and 2 patients after pathological evaluation in Group 1,respectively. T2a, T2c, T3a and T3b were reported in 13 patients, 47 patients, 5 patients and 1 patient in the other group, respectively. CONCLUSION: The final pathology showed that there is no difference in the positive surgical margin, proportion of insignificant prostate cancer and Gleason upgrading between groups. The clinicians must be aware of the fact that active surveillance can be misdiagnosed in some patients (Tab. 2, Ref. 20).
Subject(s)
Population Surveillance , Prostate-Specific Antigen/blood , Prostatectomy , Prostatic Neoplasms/pathology , Prostatic Neoplasms/surgery , Aged , Humans , Male , Middle Aged , Neoplasm Grading , Organ Size , Prostate/pathology , Prostatic Neoplasms/mortality , Retrospective Studies , Survival Analysis , Treatment OutcomeABSTRACT
OBJECTIVES: Ureteropelvic junction (UPJ) obstruction is of critical importance to understand the histopathology of UPJ obstruction in terms of therapy planning and follow-up. For this purpose, our study was conducted with TNF-α and TGF-ß markers to investigate possible underlying problems in intrinsic UPJ obstruction. METHODS: Of the patients who had undergone surgery in our clinic, 36 UPJ segments of patients who had undergone dismembered pyeloplasty surgery due to UPJ obstruction and 14 UPJ segments of the patients who had undergone nephrectomy were collected to form 2 groups. All histological sections were examined by applying immunohistochemical transforming growth factor beta 3 (TGF-ß3) and tumour necrosis factor alpha (TNF-α) monoclonal antibody dyes. RESULTS: The mean staining values for TNF-α in mucosal tissue and mucosa were 0.53±0.84 and 0.58±0.84, respectively in the obstruction group, whereas the values observed in the control group were 0.86±0.36 and 0.93±0.47, respectively. While the mean staining values in the obstruction group in mucosal tissue and mucosa for TGF-ß3 were 1.75±0.73 and 2.17±0.77, respectively, the values established in the control group were 1.14±0.66 and 1.43±0.93, respectively. The difference between the obstruction and control groups were statistically significant for both values (p<0.05). CONCLUSION: Only a limited number of studies have been carried out on this particular issue. Data from the present study indicate that TGF-ß3 and TNF-α may play a role in the histopathogenesis of UPJ obstruction (Tab. 1, Fig. 1, Ref. 18).
Subject(s)
Kidney Pelvis , Transforming Growth Factor beta3/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis , Ureteral Obstruction/metabolism , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Middle Aged , Young AdultABSTRACT
Doxorubicin (DXR) is widely used in cancer treatment. However, it has not yet been possible to prevent the side effects of DXR. The aim of this study was to investigate the hepatoprotective effect of crocin against DXR used in cancer treatment. For this reason; forty Wistar rats (male-250-300 g) were allocated into four groups (n = 10/group): Control, Crocin, DXR and DXR+Crocin. Control and Crocin groups were administered saline and crocin (40 mg/kg, i.p) for 15 days, respectively. DXR group, cumulative dose 12 mg/kg DXR, was administered for 12 days via 48 h intervals in six injections (2 mg/kg each, i.p). DXR+Crocin group, crocin (40 mg/kg-i.p) was administered for 15 days, and DXR was given as in the DXR group. The results revealed that serum liver markers (alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) increased significantly after DXR administration but recovered after crocin therapy. In addition, lipid peroxidation (MDA), and inflammatory cytokine (TNF-α) increased after DXR application and the antioxidative defense system (GSH, SOD, CAT) significantly decreased and re-achieved by crocin treatment. Our results conclude that crocin treatment was related to ameliorated hepatocellular architecture and reduced hepatic oxidative stress and inflammation in rats with DXR-induced hepatotoxicity.
Subject(s)
Antioxidants , Chemical and Drug Induced Liver Injury , Rats , Male , Animals , Antioxidants/pharmacology , Antioxidants/metabolism , Rats, Wistar , Oxidative Stress , Liver , Doxorubicin/toxicity , Biomarkers/metabolism , Chemical and Drug Induced Liver Injury/drug therapy , Chemical and Drug Induced Liver Injury/metabolism , Anti-Inflammatory Agents/pharmacologyABSTRACT
Lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) are frequently encountered in ageing males. We compared the efficacy of alfuzosin 10 mg alone or in combination with sildenafil 50 mg in the treatment of LUTS due to benign prostatic hyperplasia. One hundred male patients older than 45 years were randomized to two groups containing 50 patients each; one group receiving alfuzosin 10 mg and the other group alfuzosin 10 mg combined with sildenafil 50 mg. International Prostate Symptom Score (IPSS), quality of life (QoL), maximum flow rate (Q(max)), prostate volume and post-void residual urine were evaluated. The mean age was 60.2 ± 17.8. Mean data of evaluated parameters in both groups at the end of 3rd month compared with baseline values are given respective order as; 5.1 (26.8%) and 5.8 (28.2%) points decreases in IPSS; 1.6 (41.1%) and 1.8 (45%) points decreases in QoL; and 3.4 (29.6%) and 3.4 (33%) points increases in Q(max) . The outcomes of our study cannot be interpreted in such a way to report that alpha blocker-PDE5 inhibitor combination has a better efficacy than alpha blocker treatment alone in patients with LUTS.
Subject(s)
Adrenergic alpha-1 Receptor Antagonists/therapeutic use , Phosphodiesterase Inhibitors/therapeutic use , Piperazines/therapeutic use , Prostatic Hyperplasia/complications , Quinazolines/therapeutic use , Sulfones/therapeutic use , Urination Disorders/drug therapy , Adrenergic alpha-1 Receptor Antagonists/administration & dosage , Adult , Aged , Drug Therapy, Combination , Humans , Male , Middle Aged , Phosphodiesterase Inhibitors/administration & dosage , Piperazines/administration & dosage , Purines/administration & dosage , Purines/therapeutic use , Quinazolines/administration & dosage , Sildenafil Citrate , Sulfones/administration & dosage , Urination Disorders/etiologySubject(s)
Granuloma/diagnosis , Prostatitis/diagnosis , Biopsy, Needle , Eosinophilic Granuloma/diagnosis , Eosinophilic Granuloma/pathology , Granuloma/pathology , Humans , Male , Postoperative Complications/diagnosis , Postoperative Complications/pathology , Prostatitis/pathology , Transurethral Resection of Prostate , Tuberculoma/diagnosis , Tuberculoma/pathology , Tuberculosis, Male Genital/diagnosis , Tuberculosis, Male Genital/pathologyABSTRACT
The DIGISONIC is a digitized 15-channel cochlear implant. A special version of this implant has been designed for use in the totally obstructed cochlea. This device has 10 separate electrodes that may be inserted, one by one, into 10 different holes drilled in the bony cochlea. The device's 128-point Fast Fourier Transform analysis supplies the patient with the entire set of the sound information between 100 and 7800 Hz. The stimulation rhythm is set at a programmable frequency among 125 and 400 Hz or slaved to the fundamental pitch frequency. The flexibility of the microprocessor makes it possible to select the best width and mean value of each frequency band for each electrode. Many speech-coding strategies may be easily programmed as a function of scientific desiderata. The authors present clinical results for the first 28 patients they treated with this cochlear implant.
Subject(s)
Cochlear Implants , Deafness/rehabilitation , Adolescent , Adult , Aged , Algorithms , Child , Child, Preschool , Equipment Design , Female , Fourier Analysis , Humans , Male , Middle Aged , Signal Processing, Computer-Assisted , SoftwareABSTRACT
The Digisonic is a totally digitised multichannel cochlear implant remarkable for the versatility of its sound signal processing. Owing to its flexible and articulated array, its 15 electrodes are usually introduced in the scala tympani. A special version of this device has been designed to be used in case of total obstructed cochlea. It consists of separated electrodes which may be inserted one by one in the inner ear in different holes gently drilled in the bony cochlea. The possibilities of the microprocessor allow the speech therapist to carefully select the best width and mean value of each frequency band respectively devoted to each functional electrode. These parameters may be adapted to progressively improve the patient's hearing performances as a function of his phonemic discrimination and or the number and the tonotopy of his functional electrodes. Moreover, owing to the versatility of this digitised emitter a lot of speech coding strategies may be easily programmed as a function of eventual desiderata. Its high miniaturisation leads this implant to be particularly useful for young children. Results of our 38 first implanted patients (age 2-74; mean 42) including 7 cases of totally obstructed cochlea are reported.
Subject(s)
Cochlear Implants , Deafness/therapy , Signal Processing, Computer-Assisted , Adolescent , Adult , Aged , Child , Child, Preschool , Evaluation Studies as Topic , France , Humans , Middle AgedABSTRACT
The aim of this study was to analyze the impact of patient age and education level on the comprehension of the Turkish version of Index of Erectile Function (IIEF), and to determine the patient characteristics that make this questionnaire less reliable. In this study, 238 male patients presenting to our clinic were enrolled. The patients were asked to complete the Turkish version of the IIEF questionnaire upon arrival by themselves and then once again during their second visit with the assistance of a physician. 'Accurate' comprehension of the IIEF was considered to be the consistency between the 'self-administered' and 'physician-assisted' IIEF scores. The impact of patient age and education level on the 'accurate' comprehension of the IIEF was analyzed. There was a significant difference between the 'self-administered' and 'physician-assisted' IIEF scores in patients ≥ 60 years of age (P=0.045) and primary school graduates (P=0.015). Age ≥ 60 years and being primary school graduate are factors lowering the comprehension of the Turkish version of the IIEF by the patients. Older patients and patients with lower education could benefit from the assistance of a physician while completing this questionnaire.
Subject(s)
Erectile Dysfunction/physiopathology , Penile Erection/physiology , Adult , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Severity of Illness Index , Surveys and Questionnaires , TurkeyABSTRACT
Glossopharyngeal neuralgia is a rare disease. In this report; six cases of glossopharyngeal neuralgia have been studied. At first, drug therapy was used in all of the 6 cases. In 2 of the 6 cases which were resistant to medical therapy intracranial section of the 9th nerve as well as the upper two rootlets of the 10th nerve were performed. This resolved the symptoms completely. One of these two cases, had, in addition to pain paroxyms, hypotension, bradycardia and syncope, which were controlled by temporary cardiac pacemaker. In the other 4 cases, drug therapy was able to control the paroxysms of pain. In addition, two patients with weight loss and one patient with bradycardia rapidly responded to drug therapy as well. Reviewing the literature, we discuss the medical and surgical treatment of glossopharyngeal neuralgia and possible mechanisms of associated cardiovascular disturbances.